CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-28 | GILLIS JONATHAN CAAO and PAO | Sale 10b5-1 | −700 | $30.83 | $22K | 181,219 |
| 2026-04-27 | Kreitzer Anatol Chief Discovery Officer | Sale 10b5-1 | −8,346 | $28.96 | $242K | 248,266 |
| 2026-04-27 | Kreitzer Anatol Chief Discovery Officer | Sale 10b5-1 | −29,255 | $29.63 | $867K | 219,011 |
| 2026-04-27 | Kreitzer Anatol Chief Discovery Officer | Sale 10b5-1 | −7,821 | $30.50 | $239K | 211,190 |
| 2026-04-27 | GILLIS JONATHAN CAAO and PAO | Sale 10b5-1 | −7,914 | $28.94 | $229K | 243,140 |
| 2026-04-27 | GILLIS JONATHAN CAAO and PAO | Sale 10b5-1 | −29,623 | $29.60 | $877K | 213,517 |
| 2026-04-27 | GILLIS JONATHAN CAAO and PAO | Sale 10b5-1 | −14,363 | $30.46 | $437K | 199,154 |
| 2026-04-16 | Setia Vishwas Chief Financial Officer | Sale | −29 | $27.01 | $783 | 392,714 |
| 2026-04-16 | Setia Vishwas Chief Financial Officer | Sale | −87 | $27.49 | $2K | 392,627 |
| 2026-04-16 | Foff Erin Pennock Chief Medical Officer | Sale | −288 | $27.01 | $8K | 401,658 |
| 2026-04-16 | Foff Erin Pennock Chief Medical Officer | Sale | −881 | $27.49 | $24K | 400,777 |
| 2026-04-16 | Hanson Kristopher General Counsel | Sale | −73 | $27.01 | $2K | 190,390 |
| 2026-04-16 | Hanson Kristopher General Counsel | Sale | −225 | $27.49 | $6K | 190,165 |
| 2026-04-16 | Lillie James Woodruff Chief Scientific Officer | Sale | −686 | $27.01 | $19K | 297,254 |
| 2026-04-16 | Lillie James Woodruff Chief Scientific Officer | Sale | −2,097 | $27.49 | $58K | 295,157 |
| 2026-04-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −2,477 | $27.01 | $67K | 1,638,139 |
| 2026-04-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −7,575 | $27.49 | $208K | 1,630,564 |
| 2026-04-15 | Setia Vishwas Chief Financial Officer | Sale | −2,806 | $26.87 | $75K | 392,743 |
| 2026-04-15 | Kreitzer Anatol Chief Discovery Officer | Sale | −3,316 | $26.61 | $88K | 256,612 |
| 2026-04-15 | Foff Erin Pennock Chief Medical Officer | Sale | −2,044 | $26.84 | $55K | 401,946 |
Page 8 of 12 · 239 trades